SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-18-053380
Filing Date
2018-08-23
Accepted
2018-08-23 17:00:34
Documents
2
Period of Report
2018-08-23
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a18-21141_18k.htm 8-K 28482
2 EX-99.1 a18-21141_1ex99d1.htm EX-99.1 27809
  Complete submission text file 0001104659-18-053380.txt   57434
Mailing Address 100 BEAVER STREET SUITE 201 WALTHAM MA 02453
Business Address 100 BEAVER STREET SUITE 201 WALTHAM MA 02453 781-996-5252
Kala Pharmaceuticals, Inc. (Filer) CIK: 0001479419 (see all company filings)

IRS No.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38150 | Film No.: 181035262
SIC: 2834 Pharmaceutical Preparations